Both of those drugs already carry warnings about suicidal thoughts and behaviour on their labels in the US and highlight the need to monitor patients taking them for signs of emerging or worsening depression
I mean, not everyone is going to want to inject something weekly for weight loss
The FDA approval acknowledges that GLP-1 receptor agonists can play a vital role in reducing the risk of Major Adverse Cardiovascular Events (MACE), such as heart attack, stroke, and cardiovascular death, particularly in adults with established cardiovascular disease and obesity or overweight
Eric Topol (42:01): I share those, especially since we don't have a way to get people off if people could and maintain their weight or that
In comparison of food intake during an ad libitum buffet meal, treatment with pramlintide resulted in an approximately 200 calorie decrease in food intake compared to placebo administration (430)
And because Tesamorelin preserves pulsatility rather than creating a flat and supraphysiological reading of GH (like exogenous HGH does), you get the metabolic benefits without the downsides of shutting down your own production